Healthverity
OverviewSuggest Edit
HealthVerity is developing an important set of proprietary technologies and software tools that enable its customers, including pharmaceutical manufacturers, hospitals and health insurers, and healthcare technology suppliers to rapidly discover, license and assemble patient data from a wide range of traditional and emerging healthcare data sources. The company’s solutions are targeted toward enhancing the ability of organizations to generate new patient insights from existing and new healthcare data sources.
| Type | Private | |
| Founded | 2014 | |
| HQ | Philadelphia, PA, US | Map |
| Website | healthverity.com | |
| Employee Ratings | More |
Recent NewsAll News
- Ciox Health and HealthVerity Announce Partnership to Enable First-in-Kind Decentralized Clinical Trial
- HealthVerity Awarded U.S. Patent for Privacy-Preserving Analysis for Secure Multi-Party Computing
- HealthVerity and Medidata Announce Strategic Partnership to Advance Real World Evidence During and After Clinical Trials
- HealthVerity Joins Accenture's INTIENT Network to Help Drive Innovation in Drug Discovery, Scientific Research and Improve Patient Outcomes
Latest Updates
| Employees (est.) (Mar 2021) | 119 | |
| Cybersecurity rating | A | More |
Key People/Management at Healthverity
Andrew Kress
Co-Founder and CEO
Amanda Elefante
VP, People
Austin Eliazar
Chief Data Scientist
Tara Harding
VP, Revenue Operations
Dominique Hurley
VP, Strategy & Innovation
David Pinski
VP, Product Management
Healthverity Office Locations
Healthverity has an office in Philadelphia
Philadelphia, PA, US (HQ)
1818 Market Street, 1818 Market St #200
Healthverity Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Healthverity total Funding | $42.2 m |
Healthverity latest funding size | $25 m |
Time since last funding | 2 years ago |
Healthverity investors | Greycroft, Foresite Capital, Flare Capital Partners |
Healthverity's latest funding round in April 2019 was reported to be $25 m. In total, Healthverity has raised $42.2 m
Healthverity Cybersecurity Score
Healthverity Online and Social Media Presence
610 Twitter followers
Healthverity has 610 Twitter Followers. The number of followers has increased 0.3% month over month and increased 3.4% quarter over quarter
Healthverity's Trends
Twitter Engagement Stats for @healthverity
2.1k
Tweets
677
Following
610
Followers
3
Tweets last 30 days
0.3
Avg. likes per Tweet
100%
Tweets with engagement
Healthverity News and Updates
February 10, 2021
Ciox Health and HealthVerity Announce Partnership to Enable First-in-Kind Decentralized Clinical Trial
ALPHARETTA, Ga., Feb. 10, 2021 /PRNewswire/ -- Ciox Health, a leading health technology company, today announced a strategic collaboration between its Real World Data (RWD) Division and HealthVerity, the leader in privacy-protected data exchange. By pairing HealthVerity's real-world data...
December 09, 2020
HealthVerity Awarded U.S. Patent for Privacy-Preserving Analysis for Secure Multi-Party Computing
PHILADELPHIA, Dec. 9, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, announced today that the U.S. Patent and Trademark Office ("USPTO") issued U.S. Pat. No. 10,824,738 on November 3, 2020 in support of HealthVerity's privacy-preserving technology that...
November 20, 2020
HealthVerity and Medidata Announce Strategic Partnership to Advance Real World Evidence During and After Clinical Trials
PHILADELPHIA, Nov. 20, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today announced a strategic collaboration with Medidata, a Dassault Systèmes company, the global leader in creating end-to-end solutions to support the entire clinical development...
November 18, 2020
HealthVerity Joins Accenture's INTIENT Network to Help Drive Innovation in Drug Discovery, Scientific Research and Improve Patient Outcomes
PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- HealthVerity, a leader in privacy-protected data exchange, has joined the INTIENT Network ecosystem which is designed to help independent software vendors (ISV) and life sciences companies collaborate more effectively to accelerate drug...
November 16, 2020
HealthVerity launches an integrated cloud platform designed to revolutionize how healthcare enterprises approach data strategy
PHILADELPHIA, Nov. 16, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today announced the commercial availability of its integrated cloud platform offering flexible technologies that empower healthcare enterprises to design and build their own unique...
August 26, 2020
HealthVerity launches Provider Diversity Index to accelerate recruitment of minority groups into clinical trials
PHILADELPHIA, Aug. 26, 2020 /PRNewswire/ -- HealthVerity, the leader in privacy-protected data exchange, today expanded its commitment to advancing racial and ethnic diversity and inclusion in clinical trials with the launch of the "Provider Diversity Index." With more than 330 million...
Healthverity Blogs
March 04, 2021
How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of Gilead Sciences
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical trial operations while working to develop lifesaving interventions. At Gilead Sciences, this need to quickly pivot led to an increased understanding of how real-world evid…
March 02, 2021
Covid-19 antibodies may protect against reinfection later, study suggests
CNN
The post Covid-19 antibodies may protect against reinfection later, study suggests appeared first on HealthVerity.
February 24, 2021
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
National Cancer Institute
The post NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection appeared first on HealthVerity.
February 12, 2021
The role of RWE: Longitudinal patient insights bridging clinical and real-word data
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and patient insights both during and post-trial. With more immediate access to real-world data, clinical trial design, study effectiveness and real-time research can improve drastically.
January 18, 2021
2021 Data Imperatives: The pulse of the industry
The healthcare industry relies on real-world data more and more to make informed and effective decisions and the COVID-19 pandemic has highlighted this need more than ever. 2020 has proven that centralized data management, a greater ability to share and exchange data and advanced technol…
December 22, 2020
SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests
The National Cancer Institute
The post SARS-CoV-2 Antibodies Can Protect from Reinfection, NCI Study Suggests appeared first on HealthVerity.
Healthverity Frequently Asked Questions
When was Healthverity founded?
Healthverity was founded in 2014.
Who are Healthverity key executives?
Healthverity's key executives are Andrew Kress, Amanda Elefante and Austin Eliazar.
How many employees does Healthverity have?
Healthverity has 119 employees.
Who are Healthverity competitors?
Competitors of Healthverity include PinnacleCare, Verilogue and eClinicalWorks.
Where is Healthverity headquarters?
Healthverity headquarters is located at 1818 Market Street, 1818 Market St #200, Philadelphia.
Where are Healthverity offices?
Healthverity has an office in Philadelphia.
How many offices does Healthverity have?
Healthverity has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies